Cargando…
Toward the next generation of NK cell-based adoptive cancer immunotherapy
The adoptive transfer of interleukin (IL)-2-expanded natural killer (NK) cells has provided unsatisfactory clinical benefits to patients affected by solid tumors. Our study demonstrates that the activation of NK cells with IL-12/IL-15/IL-18 prior to transfer into tumor-bearing mice is critical for o...
Autores principales: | Ni, Jing, Miller, Matthias, Stojanovic, Ana, Cerwenka, Adelheid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654599/ https://www.ncbi.nlm.nih.gov/pubmed/23734329 http://dx.doi.org/10.4161/onci.23811 |
Ejemplares similares
-
HMGB1: The metabolic weapon in the arsenal of NK cells
por: Cerwenka, Adelheid, et al.
Publicado: (2016) -
NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
por: Vacca, Paola, et al.
Publicado: (2013) -
New insights into the role of NK cells in cancer immunotherapy
por: Salagianni, Maria, et al.
Publicado: (2012) -
Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
por: Ni, Jing, et al.
Publicado: (2012) -
When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma
por: Messaoudene, Meriem, et al.
Publicado: (2014)